Kuntz Sabine, Rudloff Silvia, Kunz Clemens
Institute of Nutritional Sciences, Justus-Liebig-University Giessen, Giessen, Germany.
Department of Pediatrics, Justus-Liebig-University Giessen, Giessen, Germany.
Front Nutr. 2019 Mar 28;6:31. doi: 10.3389/fnut.2019.00031. eCollection 2019.
Oligosaccharides are present in human milk (HMO) in large amounts and in a high variety: Among other functions they are considered to influence the gut microbiota and gut maturation in infants. Due to the large volume of milk available bovine milk oligosaccharides (BMO) may be an alternative source of functional ingredients to potentially mimic HMO functions. Thus, we investigated direct effects of bovine milk oligosaccharides (BMO) from different cattle breeds on proliferation, differentiation and apoptosis in transformed (HT-29 and Caco-2) and non-transformed human intestinal cells (HIE cells). We observed a profound growth-inhibition effect induced by all BMO isolates in HT-29, Caco-2, and HIE cells in a dose-dependent manner. The effects varied not only between cell lines, i.e., HT-29 and Caco-2 cells were more sensitive than HIE cells, but also between the cattle breeds. Regarding the induction of differentiation, BMO induced differentiation only in HIE cells without affecting apoptosis. Cell cycle analysis via flow cytometry showed that growth inhibition was associated with a G2/M arrest in all cell lines. Expression levels detected by quantitative real-time RT-PCR revealed that this G2/M arrest was associated with changes in mRNA expression levels of cyclin A and B. Cyclin-dependent kinase inhibitors p21 and p27 and the tumor suppressor p53 were only enhanced in HIE cells necessary for arresting cells in the G2/M phase and induction of differentiation. In HT-29 and Caco-2 cells, a loss of p53 expression failed to induce G2/M associated induction of differentiation. The HIE cell specific differentiation induced by BMO was a result of influencing the phosphorylation states of EGFR (epidermal growth factor receptor) and MAP kinase, i.e., ERK1/2 (extracellular signal-regulated kinase 1/2), p38-α, and Akt2 phosphorylation. These results suggest that BMO inhibited intestinal cell proliferation and altered cell cycle dynamics by affecting corresponding regulator genes and mitogen-activated protein kinase signaling. As the development and maturation of digestive and absorptive processes depends on gut differentiation processes, our experiments show that breed-specific BMO are natural substances influencing various parameter which may be important in gastrointestinal development. This, however, needs to be proven in future studies.
低聚糖大量且多样地存在于人乳(HMO)中:在诸多功能中,它们被认为会影响婴儿的肠道微生物群和肠道成熟。由于有大量的牛乳,牛乳低聚糖(BMO)可能是一种潜在模拟HMO功能的功能性成分的替代来源。因此,我们研究了来自不同牛品种的牛乳低聚糖(BMO)对转化的(HT - 29和Caco - 2)和未转化的人肠道细胞(HIE细胞)的增殖、分化和凋亡的直接影响。我们观察到所有BMO分离物在HT - 29、Caco - 2和HIE细胞中均以剂量依赖性方式诱导了显著的生长抑制作用。这些影响不仅在细胞系之间有所不同,即HT - 29和Caco - 2细胞比HIE细胞更敏感,而且在牛品种之间也存在差异。关于分化的诱导,BMO仅在HIE细胞中诱导分化,而不影响凋亡。通过流式细胞术进行的细胞周期分析表明,生长抑制与所有细胞系中的G2/M期阻滞有关。通过定量实时RT - PCR检测的表达水平显示,这种G2/M期阻滞与细胞周期蛋白A和B的mRNA表达水平变化有关。细胞周期蛋白依赖性激酶抑制剂p21和p27以及肿瘤抑制因子p53仅在HIE细胞中增强,这些细胞对于将细胞阻滞在G2/M期和诱导分化是必需的。在HT - 29和Caco - 2细胞中,p53表达的缺失未能诱导与G2/M相关的分化诱导。BMO诱导的HIE细胞特异性分化是影响表皮生长因子受体(EGFR)和丝裂原活化蛋白激酶,即细胞外信号调节激酶1/2(ERK1/2)、p38 - α和Akt2磷酸化状态的结果。这些结果表明,BMO通过影响相应的调节基因和丝裂原活化蛋白激酶信号传导来抑制肠道细胞增殖并改变细胞周期动态。由于消化和吸收过程的发育和成熟取决于肠道分化过程,我们的实验表明,品种特异性的BMO是影响各种参数的天然物质,这些参数在胃肠道发育中可能很重要。然而,这需要在未来的研究中得到证实。